isocarboxazid has been researched along with Aura in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CARTER, CH | 1 |
| Riehl, JL | 1 |
| Lee, DK | 1 |
| Andrews, JM | 1 |
| Brown, WJ | 1 |
2 other studies available for isocarboxazid and Aura
| Article | Year |
|---|---|
A preliminary report on the effect of isocarboxazid in grand mal seizures.
Topics: Epilepsy; Humans; Hydrazines; Isocarboxazid; Monoamine Oxidase Inhibitors; Seizures | 1961 |
Electrophysiological and neuropharmacological studies in a patient with Unverricht-Lafora's disease.
Topics: Amphetamine; Atropine; Child; Chlordiazepoxide; Cytoplasmic Granules; Diphenhydramine; Electroenceph | 1967 |